{"transactions":[{"id":942380,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69682,"kind":"person","name":"van der Kamp Hilde Johanna","position":1,"cik":"0002000565","reported_name":"van der Kamp Hilde Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-01-09T19:34:59.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":15300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date."}],"balance_after":15300,"derivative":{"exercise_price":35.45,"expiration_date":"2036-01-07","underlying":"Ordinary Shares","underlying_shares":15300},"source":{"system":"sec-edgar","filing":"0001193125-26-009274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2000565/000119312526009274/ownership.xml","form_type":"4"}},{"id":942379,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69682,"kind":"person","name":"van der Kamp Hilde Johanna","position":1,"cik":"0002000565","reported_name":"van der Kamp Hilde Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-09T19:34:59.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2026 for no consideration."}],"balance_after":10360,"source":{"system":"sec-edgar","filing":"0001193125-26-009274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000565/000119312526009274/ownership.xml","form_type":"4"}},{"id":1306947,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69682,"kind":"person","name":"van der Kamp Hilde Johanna","position":1,"cik":"0002000565","reported_name":"van der Kamp Hilde Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-01-08T17:58:40.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the option will vest on January 6, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date."}],"balance_after":32500,"derivative":{"exercise_price":25.85,"expiration_date":"2035-01-06","underlying":"Ordinary Shares","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0000950170-25-003556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2000565/000095017025003556/ownership.xml","form_type":"4"}},{"id":1306946,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69682,"kind":"person","name":"van der Kamp Hilde Johanna","position":1,"cik":"0002000565","reported_name":"van der Kamp Hilde Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-08T17:58:40.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":6960,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2025 for no consideration."}],"balance_after":6960,"source":{"system":"sec-edgar","filing":"0000950170-25-003556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000565/000095017025003556/ownership.xml","form_type":"4"}},{"id":1693431,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":69682,"kind":"person","name":"van der Kamp Hilde Johanna","position":1,"cik":"0002000565","reported_name":"van der Kamp Hilde Johanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-01-03T17:19:15.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":11.17,"expiration_date":"2034-01-01","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-001133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000565/000095017024001133/ownership.xml","form_type":"4"}}]}